 |
|
Search Term:
OBERG K. see all results for oberg
|
Öberg K.
|
|
Author
|
A Study of Biological Behavior Based on the Expression of a Proliferating Antigen in Neuroendocrine Tumors of the Digestive System
|
|
Tumor Biology 1992, Vol. 13, No. 1-2
|
|
Author
|
Assignment of the mouse homologue of a human MEN1 candidate gene, phospholipase C- 3 (Plcb3), to chromosome region 19B by FISH
|
|
Cytogenetic and Genome Research 1995, Vol. 71, No. 3
|
|
Author
|
Biological Aspects of Neuroendocrine Gastro-Enteropancreatic Tumours
|
|
Digestion 1996, Vol. 57, Suppl. 1
|
|
Author
|
Editorial
|
|
Digestion 2000, Vol. 62, Suppl. 1
|
|
Author
|
Efficient Human Interferon- Gene Transfer to Neuroendocrine Tumor Cells with Long-Term and Stable Expression
|
|
Neuroendocrinology 2005, Vol. 82, No. 5-6
|
|
Author
|
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Biotherapy
|
|
Neuroendocrinology 2009, Vol. 90, No. 2
|
|
Author
|
Established Clinical Use of Octreotide and Lanreotide in Oncology
|
|
Chemotherapy 2001, Vol. 47, Suppl. 2
|
|
Author
|
Expression and Function of Vinculin in Neuroendocrine Tumors
|
|
Tumor Biology 2007, Vol. 28, No. 4
|
|
Author
|
Expression of Tyrosine Kinase Receptors in Lung Carcinoids
|
|
Tumor Biology 2006, Vol. 27, No. 3
|
|
Author
|
Future Aspects of Somatostatin- Receptor-Mediated Therapy
|
|
Neuroendocrinology 2004, Vol. 80, Suppl. 1
|
|
Author
|
Gene Transfer of Vasostatin, a Calreticulin Fragment, into Neuroendocrine Tumor Cells Results in Enhanced Malignant Behavior
|
|
Neuroendocrinology 2005, Vol. 82, No. 1
|
|
Author
|
Guidelines for the Diagnosis and Treatment of Neuroendocrine Gastrointestinal Tumours
|
|
Neuroendocrinology 2004, Vol. 80, No. 6
|
|
Author
|
Interf erons Alone or in Combination with Chemotherapy or Other Biologicals in the Treatment of Neuroendocrine Gut and Pancreatic Tumors
|
|
Digestion 1994, Vol. 55, Suppl. 3
|
|
Author
|
Interferon in the Management of Neuroendocrine GEP-Tumors
|
|
Digestion 2000, Vol. 62, Suppl. 1
|
|
Author
|
lnterferon- versus Somatostatin or the Combination of Both in Gastro-Enteropancreatic Tumours
|
|
Digestion 1996, Vol. 57, Suppl. 1
|
|
Author
|
Management of Neuroendocrine Tumors: A Meeting of Experts from Latin America
|
|
Neuroendocrinology 2008, Vol. 88, No. 3
|
|
Author
|
Poorly-Differentiated Endocrine Carcinomas of Midgut and Hindgut Origin
|
|
Neuroendocrinology 2008, Vol. 87, No. 1
|
|
Author
|
Regression of a Large Malignant Gastrinoma on Treatment with Sandostatin LAR®: A Case Report
|
|
Digestion 2008, Vol. 77, No. 2
|
|
Author
|
The Ultimate Biochemical Diagnosis of Gastro-Enteropancreatic Tumours
|
|
Digestion 1996, Vol. 57, Suppl. 1
|
|
Author
|
Tumor Markers in Neuroendocrine Tumors
|
|
Digestion 2000, Vol. 62, Suppl. 1
|
|
Author
|
Well-Differentiated Pancreatic Nonfunctioning Tumors/Carcinoma
|
|
Neuroendocrinology 2006, Vol. 84, No. 3
|
|
Author
|
Well-Differentiated Pancreatic Tumor/Carcinoma: Insulinoma
|
|
Neuroendocrinology 2006, Vol. 84, No. 3
|
Oberg K.
|
|
Author
|
15. Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas
|
|
Tumor Biology 1987, Vol. 8, No. 2-3
|
|
Author
|
Interferon Alpha Induction of Stat1 and Stat2 and Their Prognostic Significance in Carcinoid Tumors
|
|
Oncology 2001, Vol. 60, No. 4
|
Öberg K., Uppsala
|
|
Editor
|
Role of Somatostatin Analogues in Oncology (2000)
|